
December 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, NHS, corruption, lung cancer, opiods crisis, opioids

December 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, market access, pharma

December 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

December 5, 2019 Manufacturing and Production Border Force, Diazepam, NHS, anxiety, opioids

December 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing desmoid fibrosis, feature, patient experience, pharma, rare disease

December 3, 2019 Manufacturing and Production, Sales and Marketing Opiod, Purdue Pharma, Richard Sackler, opiod crisis

December 3, 2019 Manufacturing and Production, Sales and Marketing AstraZeneca, pharma

December 3, 2019 Manufacturing and Production Boris, Boris Johnson, Boris NHS, Jeremy Corbyn, Labour Party, NHS, Trump

December 3, 2019 Manufacturing and Production FDA, FDA commissioner, Frank Young

December 3, 2019 Manufacturing and Production, Sales and Marketing Astellas, Audentes, acquisition, neuromuscular disease, pharma

December 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung Bioepis, biosimilars, pharma

November 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Jeremy Corbyn, NHS, Opiod, US, opiod crisis

November 28, 2019 Manufacturing and Production AstraZeneca, China, China National Reimbursement Scheme, Novartis, Roche Holding

November 28, 2019 Manufacturing and Production, Research and Development Cancer Drugs Fund, NHS, NICE, Pfizer, breast cancer, ibrance, pharma

November 28, 2019 Business Services, Manufacturing and Production Federal Substance Act, Opiod, Trump, Trump Opiod, opiod crisis